{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T18:19:25Z","timestamp":1770747565270,"version":"3.49.0"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,31]],"date-time":"2019-01-31T00:00:00Z","timestamp":1548892800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["valuehealthregionalissues.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Value in Health Regional Issues"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.vhri.2018.12.005","type":"journal-article","created":{"date-parts":[[2019,3,26]],"date-time":"2019-03-26T03:18:18Z","timestamp":1553570298000},"page":"112-120","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["A Stepwise Approach to a National Hepatitis C Screening Strategy in Malaysia to Meet the WHO 2030 Targets: Proposed Strategy, Coverage, and Costs"],"prefix":"10.1016","volume":"18","author":[{"given":"Lindsey","family":"Hiebert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Hecht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shan","family":"Soe-Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosmawati","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatiha H.","family":"Shabaruddin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syed Mukhtar","family":"Syed Mansor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maznah","family":"Dahlui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amirah","family":"Azzeri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott A.","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vhri.2018.12.005_bib1","series-title":"Global Hepatitis Report 2017","author":"World Health Organization","year":"2017"},{"issue":"4","key":"10.1016\/j.vhri.2018.12.005_bib2","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1093\/heapol\/czy018","article-title":"The investment case for hepatitis B and C in South Africa: adaptation and innovation in policy analysis for disease program scale-up","volume":"33","author":"Hecht","year":"2018","journal-title":"Health Policy Plan"},{"key":"10.1016\/j.vhri.2018.12.005_bib3","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1186\/s12879-014-0564-6","article-title":"Bridging the data gaps in the epidemiology of hepatitis C virus infection in Malaysia using multi-parameter evidence synthesis","volume":"14","author":"McDonald","year":"2014","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vhri.2018.12.005_bib4","unstructured":"Mohamed R. Hepatitis C modeling in Malaysia\u2014meeting the 2020 and 2030 targets. Oral presentation at National Viral Hepatitis Meeting, Kuala Lumpur, Malaysia; January 2017."},{"key":"10.1016\/j.vhri.2018.12.005_bib6","author":"Director General of Health, Ministry of Health Malaysia"},{"issue":"6","key":"10.1016\/j.vhri.2018.12.005_bib7","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s40258-018-0425-3","article-title":"Projections of the healthcare costs and disease burden due to hepatitis C infection under different treatment policies in Malaysia, 2018-2040","volume":"16","author":"McDonald","year":"2018","journal-title":"Appl Health Econ Health Policy"},{"key":"10.1016\/j.vhri.2018.12.005_bib8","unstructured":"Jahis R. National strategic plan for viral hepatitis: towards 2030's goal. Oral presentation at National Viral Hepatitis Meeting, Kuala Lumpur, Malaysia; January 2017."},{"key":"10.1016\/j.vhri.2018.12.005_bib9","unstructured":"Ministry of Health Malaysia. National Strategic Plan on Viral Hepatitis 2017-2030 [draft document]. Kuala Lumpur, Malaysia: Ministry of Health; 2017."},{"key":"10.1016\/j.vhri.2018.12.005_bib10","series-title":"Guidelines on Hepatitis B and C Testing","author":"World Health Organization","year":"2017"},{"issue":"3","key":"10.1016\/j.vhri.2018.12.005_bib11","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1093\/cid\/cix798","article-title":"Cost-effectiveness of one-time hepatitis C screening strategies among adolescents and young adults in primary care settings","volume":"66","author":"Assoumou","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"29","key":"10.1016\/j.vhri.2018.12.005_bib12","doi-asserted-by":"crossref","first-page":"773","DOI":"10.15585\/mmwr.mm6629a2","article-title":"The role of screening and treatment in national progress toward hepatitis C elimination\u2014Georgia, 2015\u20132016","volume":"66","author":"Nasrullah","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"18","key":"10.1016\/j.vhri.2018.12.005_bib13","doi-asserted-by":"crossref","first-page":"467","DOI":"10.15585\/mmwr.mm6518a3","article-title":"Birth cohort testing for hepatitis C virus\u2014Indian Health Service 2012-2015","volume":"65","author":"Reilley","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"3","key":"10.1016\/j.vhri.2018.12.005_bib14","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1080\/17441692.2014.984742","article-title":"Cost-effectiveness model for hepatitis C screening and treatment: implications for Egypt and other countries with high prevalence","volume":"10","author":"Kim","year":"2015","journal-title":"Global Public Health"},{"key":"10.1016\/j.vhri.2018.12.005_bib15","series-title":"Global AIDS response progress report","author":"HIV\/STI Section, Disease Control Division, Ministry of Health Malaysia","year":"2016"},{"issue":"1","key":"10.1016\/j.vhri.2018.12.005_bib16","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1365-2893.2005.00651.x","article-title":"Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies","volume":"13","author":"Micallef","year":"2006","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.vhri.2018.12.005_bib17","series-title":"Malaysian Methadone Treatment Outcome Study (MyTOS)","author":"Norsiah","year":"2016"},{"key":"10.1016\/j.vhri.2018.12.005_bib18","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.vhri.2017.05.001","article-title":"How much does management of an asthma-related event cost in a Malaysian suburban hospital?","volume":"15","author":"Yong","year":"2018","journal-title":"Value Health Reg Issues"},{"key":"10.1016\/j.vhri.2018.12.005_bib19","unstructured":"Disease Control Division, Ministry of Health Malaysia. Methadone Program in Malaysia Unit Costs. Kuala Lumpur, Malaysia: Ministry of Health Malaysia; 2017."}],"container-title":["Value in Health Regional Issues"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212109919300366?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212109919300366?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T04:45:10Z","timestamp":1565153110000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212109919300366"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":18,"alternative-id":["S2212109919300366"],"URL":"https:\/\/doi.org\/10.1016\/j.vhri.2018.12.005","relation":{},"ISSN":["2212-1099"],"issn-type":[{"value":"2212-1099","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Stepwise Approach to a National Hepatitis C Screening Strategy in Malaysia to Meet the WHO 2030 Targets: Proposed Strategy, Coverage, and Costs","name":"articletitle","label":"Article Title"},{"value":"Value in Health Regional Issues","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vhri.2018.12.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 ISPOR--The professional society for health economics and outcomes research. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}